0 items USD 0.00Search
Your search for "current partnering multiple sclerosis partnering 2010 2015" gave back 38318 results.
Cladribine, sold under the brand name Leustatin among others, is a medication used to treat hairy cell leukemia (HCL, leukemic reticuloendotheliosis...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Summary Laser Hair Removal market research report provides the newest industry data and industry future trends, allowing you to identify the products...
Catalog:
ICRW
July 2020
Price: USD 2,960.00
Summary The Multiple Sclerosis (MS) Drugs market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The...
Catalog:
HYR
March 2021
Price: USD 2,000.00
Summary Hepatocyte Growth Factor market research report provides the newest industry data and industry future trends, allowing you to identify the...
Catalog:
ICRW
December 2020
Price: USD 2,960.00
The global Multiple Sclerosis Drugs market size was valued at US$ 14290 million in 2023. With growing demand in downstream market, the Multiple...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Multiple Sclerosis (MS) Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Multiple...
Catalog:
LPI
February 2024
Price: USD 3,660.00
Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The “Multiple Sclerosis (MS) Drugs Industry Forecast” looks at past sales and reviews total world Multiple Sclerosis (MS) Drugs sales in 2022,...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Multiple Sclerosis Therapies market will undergo major...
Catalog:
Arsta
March 2023
Price: USD 3,550.00
Highlights The global Primary Progressive Multiple Sclerosis Treatment market was valued at US$ million in 2022 and is anticipated to reach US$...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Multiple Sclerosis Therapies market will undergo major...
Catalog:
Arsta
May 2022
Price: USD 3,360.00
As the global economy recovers in 2021 and the supply of the industrial chain improves, the Multiple Sclerosis Therapies market will undergo major...
Catalog:
Arsta
June 2022
Price: USD 3,360.00
The “Multiple Sclerosis Therapies Industry Forecast” looks at past sales and reviews total world Multiple Sclerosis Therapies sales in 2022,...
Catalog:
LPI
March 2023
Price: USD 3,660.00
